NCT00005880View on ClinicalTrials.gov

Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Conditions
Lung Cancer
Interventions
DRUG

budesonide

Trial Locations (1)

V5Z 4E6

British Columbia Cancer Agency, Vancouver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

British Columbia Cancer Agency

OTHER

NCT00005880 - Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia | Biotech Hunter | Biotech Hunter